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Translational global 
health: from shortage 
to science to service
The translational pipeline in bio-
medicine (from bench to bedside) 
focused the attention of the global 
research community on delivery of 
results to patients.1 The notion was 
rapidly accepted, as shown by the 
training of researchers in translational 
approaches, the establishment of 
translational research institutes, and 
the development of performance 
frameworks assessing research output 
according to effect. In the broad 
and burgeoning discipline of global 
health, no such pipeline exists. Rather, 
social science research, analyses 
of the burden of disease, policy 
frameworks, generation of low-cost 
health solutions, and the provision of 
care in resource-limited settings are 
fragmented.2 Activity exists in both 
geographical and disciplinary siloes. 
Funding sources, research groups, 
health centres, and non-governmental 
organisations are each divided by 
location and interest.2
Global health is hampered by 
political fences, an absence of global 
coordination, and insufficient 
communication. However, with 
recent honing of political will, 
galvanisation of the academic 
community, and development of 
global communication methods, 
barriers are being circumvented. We 
believe that within this emerging 
globalised health architecture, the 
time is right for the formulation of a 
framework that will translate human 
suffering into global health equity. 
Such a framework, if appropriately 
communicated, could unify the 
complex global eﬀ ort, ensuring health 
and wellbeing for all. The prospect 
of the integration of research, 
pharmaceutical, political, and non-
governmental organisation interests 
in a multistakeholder network, 
sharing a common goal, is now more 
feasible than before.3
On the basis of this platform, we 
propose that a translational lens is 
applied to global health. Such a process 
would integrate basic, social, and 
political sciences with epidemiology, 
health partnerships, and on-site 
services (ﬁ gure). This partnership will 
form a science-to-service continuum 
that is evidence-based and focused 
on the global population and 
sustainability. Although ambitious, 
we believe that such a pipeline is 
both a realistic and valuable aim. 
Findings from studies have already 
shown that integration of health 
system components improves quality, 
enhances coordination between 
services, and reduces costs.4,5 
Although our proposal does not 
need to be the deﬁ nitive and broadly 
accepted translational framework, we 
present it here to encourage debate. If 
such a framework is to be introduced, 
it needs to be widely consulted, 
broadly agreed on, and then 
disseminated to all levels of the global 
health community. Challenges lie 
both in the model’s appropriateness, 
and in the feasibility of focus and 
maintenance of global attention. 
We hope that this will initiate 
discussion and culminate in a widely 
accepted conceptual framework for 
translational global health, which 
will enhance the efficiency and 
effectiveness with which we move 
from shortage to science to service.
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